Heparin-Decorated Hydrogel Microspheres Enable Bioactive Islet Encapsulation and Sustained Glycemic Control in Diabetic Mice
ACS Applied Materials & Interfaces · 23.11.2026
DOI: 10.1021/acsami.6c15035 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 23.11.2026. Verfasst von Meng Liu und 12 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, Opening Foundation of the State Key Laboratory of Transvascular Implantation Devices.
Abstract (Originalsprache)
Type 1 diabetes mellitus (T1DM) is characterized by immune-mediated β-cell destruction and chronic insulin deficiency. Pancreatic islet transplantation offers a promising approach to restore endogenous insulin production; however, the early post-transplantation period remains a critical barrier to successful graft function, as rapid protein adsorption, coagulation activation, and inflammatory cell recruitment at the material interface can compromise encapsulated islet viability. Here, we develop heparin-decorated hydrogel microcapsules to regulate early material–host interactions and improve the performance of islet encapsulation. Heparin was incorporated into a poly-l-lysine-modified gelatin (PLL–GEL) network through electrostatic complexation, where PLL was covalently anchored onto gelatin via transglutaminase-mediated cross-linking, and subsequently integrated with sodium alginate microcapsules fabricated by electrospraying and calcium-mediated ionic gelation. The resulting microcapsules exhibited uniform morphology, structural stability, and favorable physicochemical properties. Heparin incorporation reduced fibrinogen adsorption, prolonged coagulation times, and decreased macrophage adhesion, indicating improved early hemocompatibility and reduced material-induced cellular interactions. Furthermore, macrophages exposed to heparin-containing microcapsules showed altered immune-related transcriptional responses, suggesting regulation of early host responses. Encapsulated islets maintained high viability and glucose-responsive insulin secretion in vitro. Following intraperitoneal transplantation into diabetic mice, heparin-decorated microcapsules improved graft retention and sustained glycemic control over 30 days. Collectively, this study presents a functional material strategy for optimizing the early-stage compatibility of hydrogel microcapsules in islet transplantation.
Förderung
- Natural Science Foundation of Shandong Province
- Opening Foundation of the State Key Laboratory of Transvascular Implantation Devices
Zitieren
APA
Liu, M., Jia, W., Zhou, Y., Liu, L., Shen, Q., Qi, G., Zhou, R., Yang, M., Li, M., Weng, H., Chang, J., Wang, F., & Chen, Z. (2026). Heparin-Decorated Hydrogel Microspheres Enable Bioactive Islet Encapsulation and Sustained Glycemic Control in Diabetic Mice. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c15035
Vancouver
Liu M, Jia W, Zhou Y, Liu L, Shen Q, Qi G, et al. Heparin-Decorated Hydrogel Microspheres Enable Bioactive Islet Encapsulation and Sustained Glycemic Control in Diabetic Mice. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c15035
BibTeX
@article{Liu2026,
author = {Liu, Meng and Jia, Weibin and Zhou, Yuanmeng and Liu, Liling and Shen, Qianqian and Qi, Guozhen and Zhou, Ruipiao and Yang, Mengran and Li, Min and Weng, Hongjuan and Chang, Jiaqi and Wang, Fengshan and Chen, Zonggang},
title = {Heparin-Decorated Hydrogel Microspheres Enable Bioactive Islet Encapsulation and Sustained Glycemic Control in Diabetic Mice},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
doi = {10.1021/acsami.6c15035}
}
EUVIMED